Table 3.

Effect of l-arginine on [¹⁸F]FDG uptake (SUVmean) in skeletal muscle, subcutaneous and visceral WAT, liver and brain in Europid and South Asian men

SUVmean	Europid (n = 10)		South Asian (n = 10)		All (n = 20)
	Placebo	l-Arginine	Placebo	l-Arginine	Placebo	l-Arginine
SM	0.63 ± 0.02	0.62 ± 0.02	0.61 ± 0.02	0.61 ± 0.02	0.62 ± 0.02	0.62 ± 0.02
sWAT	0.17 ± 0.01	0.17 ± 0.01	0.20 ± 0.01	0.19 ± 0.01	0.18 ± 0.01	0.18 ± 0.01
vWAT	0.31 ± 0.03	0.33 ± 0.02	0.29 ± 0.03	0.31 ± 0.03	0.30 ± 0.03	0.32 ± 0.02
Liver	2.43 ± 0.05	2.50 ± 0.08	2.42 ± 0.09	2.58 ± 0.09	2.43 ± 0.07	2.54 ± 0.09
Brain	8.8 ± 0.4	8.9 ± 0.5	8.3 ± 0.5	8.1 ± 0.4	8.5 ± 0.4	8.5 ± 0.5

Data are expressed as mean ± SEM

SM, skeletal muscle; sWAT, subcutaneous white adipose tissue; vWAT, visceral white adipose tissue